Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Enzon Pharma (ENZN) to Trim Workforce by About Half
December 20, 2012 5:13 PM ESTOn December 17, 2012, Enzon Pharmaceuticals, Inc. (the Company) issued a press release announcing that its Board of Directors (the Board) has retained Lazard to act as a financial advisor in a review of the possible sale or disposition of one or more corporate assets, or a sale of the Company. The Company... More
